1500 E. Medical Center Dr, D1205 MPB, SPC 5718
Ann Arbor, MI 48109
Available to mentor
I am the Division Director for Pediatric Endocrinology. I am also the Medical Director of the Pediatric Diabetes Program.
I oversee both the inpatient and outpatient endocrinology program. I see a wide variety of patients with pediatric endocrine issues, providing comprehensive care to patients with diabetes mellitus, including type 1, type 2, neonatal diabetes and MODY. As the Medical Director of the Pediatric Diabetes Program, I manage the education and clinical program, which is certified by the State of Michigan and recognized by the American Diabetes Association. I co-founded the Multidisciplinary Pediatric Endocrine Surgery and the Multidisciplinary Osteogenesis Imperfecta Clinics, which are unique programs in the State of Michigan, which offers expert care for children with rare endocrine disorders.
-
Pediatric Endocrinology FellowshipUniversity of Michigan Health System, Ann Arbor, 2009
-
Pediatric ResidencyUniversity of Michigan Health System, Ann Arbor, 2006
-
Center MemberCaswell Diabetes Institute
I serve as the Associate Director for Pediatric Clinical Research and Diabetes Program with the Caswell Diabetes Institute, supporting the overarching mission to support rigorous science and its integration with patient-centered clinical care. I am the principal investigator for the University of Michigan Type 1 Diabetes TrialNet site (www.diabetestrialnet.org), which is a National Institutes of Health-funded international collaboration that is dedicated to the study, prevention, and early treatment of type 1 diabetes. I am also the site principal investigator for the TADPOL (diabetes, funded by JDRF/Indiana) and Libelula Precocious Puberty (Debiopharm) study.
-
Iyengar JJ, Ang L, Rodeman KB, Rao A, Lin YK, Broome DT, Fanous N, Reinert RB, Konigsberg A, Weatherup E, Hagar C, Rogosch D, Florek J, Carey B, Wyckoff J, Lee J, Thomas IH, Soleimanpour SA. Endocr Pract, 2024 Feb; 30 (2): 113 - 121.Journal ArticleA Novel Receivership Model for Transition of Young Adults With Diabetes: Experience From a Single-center Academic Transition Program.
DOI:10.1016/j.eprac.2023.11.008 PMID: 38029926 -
Lee JM, Rusnak A, Garrity A, Hirschfeld E, Thomas IH, Wichorek M, Lee JE, Rioles NA, Ebekozien O, Corathers SD. JAMA Netw Open, 2021 Oct 1; 4 (10): e2131278Journal ArticleFeasibility of Electronic Health Record Assessment of 6 Pediatric Type 1 Diabetes Self-management Habits and Their Association With Glycemic Outcomes.
DOI:10.1001/jamanetworkopen.2021.31278 PMID: 34709387 -
Heider A, Arnold S, Lew M, Pang J, Rabah R, Bruch S, Thomas I, Menon R, Cantley R, Davenport R, Jing X. Diagn Cytopathol, 2019 Oct; 47 (10): 993 - 998.Journal ArticleMalignant risk of indeterminate pediatric thyroid nodules-An institutional experience.
DOI:10.1002/dc.24266 PMID: 31254313 -
Iyengar J, Thomas IH, Soleimanpour SA. Clin Diabetes Endocrinol, 2019 5: 3Journal ArticleTransition from pediatric to adult care in emerging adults with type 1 diabetes: a blueprint for effective receivership.
DOI:10.1186/s40842-019-0078-7 PMID: 30891310 -
Thomas IH, DiMeglio LA. Curr Osteoporos Rep, 2016 Feb; 14 (1): 1 - 9.Journal ArticleAdvances in the Classification and Treatment of Osteogenesis Imperfecta.
DOI:10.1007/s11914-016-0299-y PMID: 26861807 -
Thomas IH, Saini NK, Adhikari A, Lee JM, Kasa-Vubu JZ, Vazquez DM, Menon RK, Chen M, Fajans SS. Pediatr Diabetes, 2009 Nov; 10 (7): 492 - 496.Journal ArticleNeonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation.
DOI:10.1111/j.1399-5448.2009.00526.x PMID: 19496967 -
Thomas IH, Donohue JE, Ness KK, Dengel DR, Baker KS, Gurney JG. Cancer, 2008 Dec 1; 113 (11): 3248 - 3256.Journal ArticleBone mineral density in young adult survivors of acute lymphoblastic leukemia.
DOI:10.1002/cncr.23912 PMID: 18932250 -
Thomas I. 2024 Nov 15;PresentationTransition of Care in Type 1 Diabetes